BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1327 related articles for article (PubMed ID: 29732970)

  • 21. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
    Jain A; Sharma T; Kumar R; Katare OP; Singh B
    Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation, Characterization and Biological Activity Screening of Sodium Alginate-Gum Arabic Nanoparticles Loaded with Curcumin.
    Hassani A; Mahmood S; Enezei HH; Hussain SA; Hamad HA; Aldoghachi AF; Hagar A; Doolaanea AA; Ibrahim WN
    Molecules; 2020 May; 25(9):. PubMed ID: 32397633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
    Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
    AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
    He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
    Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical Characterization, Stability, and In Vitro Evaluation of Curcumin-Loaded Solid Lipid Nanoparticles Prepared Using Biocompatible Synthetic Lipids.
    Patra S; Dey J; Chakraborty A
    ACS Appl Bio Mater; 2023 Jul; 6(7):2785-2794. PubMed ID: 37403739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
    Sutaria D; Grandhi BK; Thakkar A; Wang J; Prabhu S
    Int J Oncol; 2012 Dec; 41(6):2260-8. PubMed ID: 23007664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.
    Patel MN; Lakkadwala S; Majrad MS; Injeti ER; Gollmer SM; Shah ZA; Boddu SH; Nesamony J
    AAPS PharmSciTech; 2014 Dec; 15(6):1498-508. PubMed ID: 25035070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The design of naproxen solid lipid nanoparticles to target skin layers.
    Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
    Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
    Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line.
    Kostrzewa T; Nowak I; Feliczak-Guzik A; Drzeżdżon J; Jacewicz D; Górska-Ponikowska M; Kuban-Jankowska A
    Int J Nanomedicine; 2023; 18():2507-2523. PubMed ID: 37197025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
    Palliyage GH; Hussein N; Mimlitz M; Weeder C; Alnasser MHA; Singh S; Ekpenyong A; Tiwari AK; Chauhan H
    Pharm Res; 2021 May; 38(5):851-871. PubMed ID: 33982225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.
    Shrotriya S; Ranpise N; Satpute P; Vidhate B
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1471-1482. PubMed ID: 28884598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
    Trivino A; Gumireddy A; Chauhan H
    AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
    Kamel AE; Fadel M; Louis D
    Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.